• FCCP

1/1

FCCP NEW

$32.00 5mg
$46.00 10mg
$83.00 25mg
  • Min. Order
  • Purity99.65%
  • Cas No370-86-5
  • Supply Ability10g
  • Update time2026-03-13

TargetMol Chemicals Inc.

TargetMol Chemicals Inc.
VIP6Y
United StatesUnited States
Enterprise Verified
Business Bank account Basic Contact Infomation Business Address Trade Company
Chemical Properties
Product Name FCCP
CAS No 370-86-5
EC-No
Min. Order
Purity 99.65%
Supply Ability 10g
Release date 2026/03/13

Company Profile Introduction

Citations

[1] Yang, G., Yang, J., Diao, Z., Long, J., Shu, Z., Liu, C., & Wan, W. (2025). Cascade-targeting pH/ROS microneedles promote scarless diabetic wound healing by macrophage metaboimmune reprogramming. Science Advances, 11 44. https://doi.org/10.1126/sciadv.adw3834
[2] Zheng, Y., Zheng, L., Dai, M., Tong, X., Wang, Z., Jia, L., Chen, Y., Gao, M., & Gong, G. (2025). Mildly uncoupling mitochondria reduces myocardial cell injury caused by hypoxia/reoxygenation. Biomedicine & Pharmacotherapy, 189, Article 118310. https://doi.org/10.1016/j.biopha.2025.118310
[3] Irena Josephina Johanna Muffels. (2025). Imaging flow cytometry-based cellular screening elucidates pathophysiology in individuals with Variants of Uncertain Significance. Genome Medicine, 17 1, 12. https://doi.org/10.1186/s13073-025-01433-9
[4] Sheng He. (2025). Targeting SARM1 as a novel neuroprotective therapy in neurotropic viral infections. Journal of Neuroinflammation, 22 1, 113. https://doi.org/10.1186/s12974-025-03423-5
[5] Muffels, Irena. J. J., Rodenburg, R., Willemen, H. L. D., van Haaften-Visser, D., Waterham, H., Eijkelkamp, N., Fuchs, S. A., & van Hasselt, P. M. (2025). Imaging flow cytometry reveals divergent mitochondrial phenotypes in mitochondrial disease patients. iScience, 28 1, Article 111496. https://doi.org/10.1016/j.isci.2024.111496

You may like

Recommended supplier